Federal Judge Rules Colgate Must Face Lawsuits Over Children’s Mouthwash Safety

A federal judge rules that Colgate-Palmolive must face claims that its "kids" mouth rinse packaging misleads parents regarding safety for children under 6.

By: AXL Media

Published: Mar 28, 2026, 8:14 AM EDT

Source: Reuters

The Mouth Rinse "Kids" Labeling Dispute

The core of the legal challenge rests on the visual presentation of Colgate's fluoride rinses. Plaintiffs in the proposed class actions argue that by using kid-friendly flavors like "Silly Strawberry" and "Bubble Fruit" alongside prominent "kids" or "children's" branding, Colgate effectively markets the product to an age group that U.S. health authorities say should not use it. Fluoride, while beneficial for dental health, can be toxic if swallowed—a significant risk for children under 6 who have not yet mastered the "spit" reflex. Judge Andrea Wood noted that consumers might not know "where to draw the line" when a product is explicitly labeled for children but contains restrictive warnings only on the back.

The Dissenting View on Toothpaste

In contrast to the mouthwash ruling, Judge Wood dismissed the lawsuit concerning Colgate’s children's toothpaste. The plaintiffs had argued that imagery showing a "full strip" of toothpaste on a brush encouraged excessive use. However, the judge found that toothpaste packaging is materially different because it includes express instructions for children aged 2 to 6 to use only a "pea-sized" amount. Wood concluded that a reasonable consumer would view the full strip of toothpaste as a generic representation of the act of brushing rather than a safety endorsement for young children.

Industry-Wide Scrutiny of Fluoride Marketing

TRANSFORMATIVE ANALYSIS: This ruling against Colgate is part of a broader "wake-up call" for the consumer goods industry regarding the marketing of over-the-counter (OTC) drugs to minors. Other major players, including Procter & Gamble (Crest), Perrigo, and Sanofi, are facing similar litigation. The legal momentum suggests a shift away from the "bright and fun" marketing school of thought for products containing active medicinal ingredients. As regulatory pressure mounts, manufacturers may be forced to redesign "kids" lines to include age-appropriateness front-and-center, moving beyond the fine print of the FDA-mandated Drug Facts panel.